HOUSTON, TX, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the appointment of Justin Van Fleet, CPA, as Chief Financial Officer, effective August 1, 2025. Mr. Van Fleet brings more than 20 years of experience in public accounting and assurance services, most recently serving as Partner at Marcum LLP (formerly Friedman LLP). In this role, he led the firm ...

Omnicell (OMCL) Q2 2025 Earnings Call July 31, 2025 08:30 AM ET Speaker0Thank you for standing by. My name is Eric, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Omnicell Second Quarter twenty twenty five Financial Results Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session.I would now like to turn the call over to Kathleen Nemeth, Senior Vice President, Investor ...

Vericel (VCEL) Q2 2025 Earnings Call July 31, 2025 08:30 AM ET Speaker0Day, and welcome to the Vericel Corporation Second Quarter twenty twenty five Earnings Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Eric Burns, Vericel's Vice President of Finance and Investor Relations. Please go ahead.Speaker1Thank you, operator, and good morning, everyone. Joining me on today's call are Vericel's President and Chief Executive Officer, Nick Colangelo and our Chief Fi ...

GE HealthCare Technologies股价下跌 - 7月30日公司股价在市场收盘前一小时下跌7 9% [1] Crude Value Insights服务内容 - 提供专注于石油和天然气行业的投资服务及社区 [1] - 重点关注现金流及具备实际增长潜力的公司 [1] - 订阅用户可使用包含50多只股票模型的账户 [2] - 提供勘探与生产企业的深入现金流分析 [2] - 包含该行业的实时聊天讨论功能 [2] 订阅优惠 - 新用户可享受两周免费试用 [3]

Glaukos (GKOS) Q2 2025 Earnings Call July 30, 2025 04:30 PM ET Company ParticipantsChris Lewis - VP - IR & Corporate AffairsThomas Burns - Chairman & CEOThomas Stephan - Vice PresidentJoseph Gilliam - President & COORohin Patel - Vice PresidentAlex Thurman - SVP & CFODavid Saxon - Managing DirectorJoanne Wuensch. - Managing DirectorRichard Newitter - Managing DirectorMichael Sarcone - Equity Research AssociateAnthony Petrone - MD - Equity ResearchConference Call ParticipantsRyan Zimmerman - MD & Medical Tec ...

ANDOVER, Mass., July 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended June 30, 2025.Recent Highlights Total revenue of $157.4 million in the second quarter of 2025, a 38% increase compared to the second quarter of 2024 Generated net income of $34.9 million or $0.92 per fully diluted share ...

BURLINGTON, Mass. and JERUSALEM, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay, a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, is proud to announce its underwriting of two new Continuing Medical Education (CME) courses designed to expand clinician knowledge and confidence in the use of Transcranial Magnetic Stimulation (TMS). These online, no-cost CME activities aim to deepen understanding of the robust clinical evidence supporting TMS, clarify distinc ...

Real-world data showing NeuroStar is effective in adolescents and young adults with depression from the world’s largest TMS outcomes datasetMALVERN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced the publication of significant real-world findings in the Journal of the American Academy of Child & Adolesce ...

SAN DIEGO, July 29, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges RxSight as well as certain of RxSight's top executives with violations of the Securities Exchange Act of 1934.If you suffered substantial losses and wish to serve as lead plaintiff of the RxSight class actio ...

公司动态 - TransMedics管理层将参加Canaccord Genuity第45届年度增长会议 演讲时间为2025年8月12日美国东部时间上午11:30 [1] - 会议提供实时网络直播及存档回放 可通过公司官网投资者关系栏目获取 [2] 公司业务 - TransMedics是全球便携式体外常温灌注及移植器官评估技术领导者 总部位于马萨诸塞州安多弗 [3] - 公司专注于解决移植器官数量不足及质量提升需求 开发了器官保存、移植前活力评估等关键技术 [3] - 技术应用覆盖终末期心、肺、肝衰竭治疗领域 有望提高捐赠器官利用率 [3] 投资者联系 - 投资者关系联系人包括Brian Johnston和Laine Morgan 联系电话332-895-3222 [4]